Skyway Urban Air Mobility Systems Market 2025: 18% CAGR Driven by Smart City Integration & eVTOL Adoption
Biometric Authentication Modules Market 2025: Rapid Growth Driven by AI Integration & 18% CAGR Forecast
Wall Street Hedge Funds Turbocharge Bets on Sana Biotechnology—Should You Buy In?
America’s Biotech Revolution Starts in North Carolina: Inside the Roadshow Uniting Innovation, Jobs, and Security
Biotech Boom: North Carolina Lands Billions in Investments and Eyes Global Leadership
TipRanks Users Beware: Accounts Disabled for Suspicious Activity—Here’s What You Need to Know in 2025
Biotech Breakthroughs: Lawmakers Chart Bold Strategies for the Next Wave of Innovation
Pipeline Integrity Engineering Market 2025: AI-Driven Monitoring Spurs 7% CAGR Growth Through 2030
Bidirectional Brain-Computer Interface Market 2025: Surging Demand Drives 28% CAGR Through 2030
Ampacity Monitoring Systems 2025: Power Grid Intelligence Set to Surge 18% CAGR
China leads a transformative biotechnology revolution, integrating it into national strategy and global ambitions. The U.S. National Security Commission on Emerging Biotechnology warns of China’s
The agricultural biotechnology market is expected to grow significantly, from USD 43.2 billion in 2025 to USD 79.7 billion by 2032. Population growth to 9
Vir Biotechnology is a prominent figure in the biotech sector, drawing both excitement and caution among analysts. Analyst price targets for Vir vary widely, from
Europe’s biotech sector, controlling 12% of the global market, is focused on innovation and biosecurity excellence. Key discussions highlight the need to balance groundbreaking biotech
The 1975 Asilomar Conference set a benchmark for safety in recombinant DNA research, pivotal for modern biotech regulation. Cambridge, MA, became a biotech hub in
Biotechnology is central to U.S. national strategy, representing a crucial battleground in the competition with China. The National Security Commission on Emerging Biotechnology’s report urges
Canada is a leader in medical innovation but often misses out on economic benefits due to inadequate commercialization. Historical examples, like insulin’s discovery, highlight Canada’s
Sana Biotechnology faced legal challenges due to alleged transparency issues with investors. The company initially showcased promising projects, SC291, SC379, and SG299, targeting B-cell malignancies
The U.S. faces a significant challenge from China’s growing biotech capabilities, threatening its global power position. A report urges the U.S. to invest billions over
The U.S. and China are in a critical biotechnology race, influencing global health, defense, and economies. The National Security Commission on Emerging Biotechnology (NSCEB) stresses
